Should azithromycin be used to treat COVID-19? A rapid review.

Published in: BJGP open (2020)

There is no evidence to support the use of azithromycin for the treatment of COVID-19 outside of the context of clinical trials, unless it is used to treat bacterial super-infection. There is extremely limited evidence of a possible synergy between azithromycin and hydroxychloroquine. The adverse events profile of azithromycin in the context of COVID-19 has not yet been established. Well-conducted clinical trials are urgently needed in this area.

Keyphrases

coronavirus disease
sars cov
clinical trial
randomized controlled trial
phase iii
replacement therapy
loop mediated isothermal amplification